hca glp 1 coverage Who Gets the Shot? GLP-1 Access by State CMS has announced important updates
Description
Possibly adding a new entrant to the highly competitive diabetes/weight loss market, Roche has announced positive interim results from an ongoing Phase I trial for its oral small molecule GLP-1 receptor agonist, CT996
En Colombia, la Encuesta Nacional de Salud y Nutricin (ENSIN) en el ao 200714, demostr que la prevalencia de DM2 fue de 5% (glicemia capilar en ayunas igual o mayor a 126mg/dl) y la de prediabetes 9% (glicemia capilar en ayunas de 100 a 125mg/dl)
In vitro studies show that GLP-1 receptor activation can improve sperm motility through a mechanism that does not depend on insulin signaling, and can enhance the metabolic activity of Sertoli cells the cellular scaffolding on which spermatogenesis depends
A Case Report, Clujul Medical 91 (2018): 117119
2022;107:e1643e1652
